This activity is supported by an independent medical educational grant from Regeneron Pharmaceuticals, Inc.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education LLC. (Evolve)
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Allen C. Ho, MD, FACS
Wills Eye Hospital
Attending Surgeon
Director of Retina Research
Professor of Ophthalmology
Thomas Jefferson University
Mid Atlantic Retina
Philadelphia, PA
President, The Retina Society
Robert Avery, MD
California Retina Consultants
Santa Barbara, CA
Avni P. Finn, MD, MBA
Northern California Retina Vitreous Associates
Mountain View, CA
Eric Nudleman, MD, PhD
Shiley Eye Institute
University of California San Diego
La Jolla, California
Ehsan Rahimy, MD
Palo Alto Medical Foundation
Palo Alto, CA
Priya Sharma Vakharia, MD
Retina Vitreous Associates of Florida
Tampa Bay, FL
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Allen C. Ho, MD, FACS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Adverum, Aerie Pharmaceuticals, AGTC, Alcon Vision, Aldeyra, Allergan, Apellis, Asclepix, Beaver-Visitec International, Chengdu Kanghong Biotechnology, Genentech, RegenXBio, MeiraGTx, Gyroscope, Clearside, Iveric/Ophthotech, Janssen/Johnson & Johnson Vision, Lineage, Notal Vision, Ocular Therapeutics, ONL, Regeneron Pharmaceuticals. Grant/Research Support: Adverum, Aerie Pharmaceuticals, AGTC, Alcon Vision, Aldeyra, Allergan, Apellis, Asclepix, Chengdu Kanghong Biotechnolog, Genentech, Graybug, Gyroscope, Iveric/Ophthotech, Janssen/Johnson & Johnson Vision, Lineage, Lumithera, MeiraGTx, National Eye Institute, Notal Vision, Novartis, ProQR, Regeneron Pharmaceuticals, and RegenXBio. Other support: Covalent.
Robert Avery, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Adverum, Allergan, Genentech, and Regenxbio. Stock/Shareholder: Adverum and Regeneron Pharmaceuticals.
Avni P. Finn, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Apellis Pharmaceuticals, and Genentech.
Eric Nudleman, MD, PhD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Genentech, and Regeneron Pharmaceuticals.
Ehsan Rahimy, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Apellis, Genentech, Google, and Regeneron Pharmaceuticals. Speaker’s List: Allergan and Regeneron Pharmaceuticals.
Priya Sharma Vakharia, MD, has no financial agreement during the past year with commercial interests.
The Evolve staff and planners have no financial relationships with commercial interests.
Michelle Dalton, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Retina Today, or Regeneron Pharmaceuticals.
